Company news

CytoSorbents Corporation news in 2025

CytoSorbents Corporation's news releases, calls and decks from 2025, newest first.

View company

CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

December 10, 2025

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

November 17, 2025

CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

November 13, 2025

CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

November 11, 2025

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

October 30, 2025

In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

October 28, 2025

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

September 29, 2025

CytoSorbents Provides DrugSorb-ATR Regulatory Update

September 16, 2025

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

September 8, 2025

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

September 5, 2025

CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

August 20, 2025

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

August 6, 2025

CytoSorbents Leads a New Era in Sepsis Treatment

July 31, 2025

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

July 29, 2025

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

July 2, 2025

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

June 24, 2025

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

May 29, 2025

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

May 22, 2025

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

May 14, 2025

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

May 1, 2025

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

April 29, 2025

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

April 21, 2025

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

April 17, 2025

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

April 14, 2025

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

April 4, 2025

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

March 31, 2025

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

March 21, 2025

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

March 4, 2025

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

February 26, 2025

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

February 25, 2025

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

January 12, 2025

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

January 5, 2025

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

January 2, 2025

Calls in 2025

Decks in 2025